Insulin-like growth factor binding protein 5: Contribution to growth and differentiation of neuroblastoma cells

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 59-68

  Cesi, Vincenzo ^a   Vitali, Roberta ^a   Tanno, Barbara ^a   Giuffrida, Maria Laura ^a   Sesti, Fabiola ^a   Mancini, Camillo ^a   Raschellà, Giuseppe ^a  

^a ENEA C R CASACCIA   (Italy)

Author keywords

Differentiation; IGF 2; IGFBP 5; LAN 5; Neuroblastoma; Retinoic acid

Indexed keywords

RETINOIC ACID; RETINOID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 5;

CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; OSTEOBLAST; PHENOTYPE; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TANDEM REPEAT; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 14944371184     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.007     Document Type: Conference Paper

References (23)

1. BERNSTEIN, M.L., J.M. LECLERC, G. BUNIN, et al. 1992. A population-based study of neuroblastoma incidence, survival, and mortality in North America. J. Clin. Oncol. 10: 323-329.
2. TSOKOS, M., S. SCARPA, R.A. ROSS & T.J. TRICHE. 1987. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am. J. Pathol. 128: 484-496.
3. AMBROS, P.F., I.M. AMBROS, S. STREHL, et al. 1995. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur. J. Cancer 31A: 510-515.
4. REYNOLDS, C.P., K.K. MATTHAY, J.G. VILLABLANCA & B.J. MAURER. 2003. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 197: 185-192.
5. EL-BADRY, O.M., L.J. HELMAN, J. CHATTEN, et al. 1991. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J. Clin. Invest. 87: 648-657.
6. ZUMKELLER, W. & M. SCHWAB. 1999. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: potential diagnostic and therapeutic perspectives. Horm. Metab. Res. 31: 138-141.
7. PAHLMAN, S., G. MEYERSON, E. LINDOREN, et al. 1991. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA 88: 9994-9998.
8. DROP, S.L., A.G. SCHULLER, D.J. LINDENBERGH-KORTLEVE, et al. 1992. Structural aspects of the IGFBP family. Growth Regul. 2: 69-79.
9. ZAPF, J. 1995. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132: 645-654.
10. TANNO, B., A. NEGRONI, R. VITALI, et al. 2002. Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. J. Biol. Chem. 277: 23172-23180.
11. DUAN, C., S.B. HAWES, T. PREVETTE & D.R. CLEMMONS. 1996. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J. Biol. Chem. 271: 4280-4288.
12. PASH, J.M. & E. CANALIS. 1996. Transcriptional regulation of insulin-like growth factor-binding protein-5 by prostaglandin E2 in osteoblast cells. Endocrinology 137: 2375-2382.
13. DUAN, C. & D.R. CLEMMONS. 1995. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem. 270: 24844-24851.
14. YEH, L.C., M.L. ADAMO, C. DUAN & J.C. LEE. 1998. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms. J. Cell Physiol. 175: 78-88.
15. HOLLY, J.M., D.C. CLAFFEY, S.C. CWYFAN-HUGHES, et al. 1993. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul. 3: 88-91.
16. MATSUMOTO, T., S.E. GARGOSKY, K. KELLEY & R.G. ROSENFELD. 1996. Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line. Growth Regul. 6: 185-190.
17. COHEN, P.S., J.J. LETTERIO, C. GAETANO, et al. 1995. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res. 55: 2380-2386.
18. SHEIKH, M.S., Z.M. SHAO, J.C. CHEN, et al. 1992. Insulin-like growth factor binding protein-5 gene expression is differentially regulated at a post-transcriptional level in retinoic acid-sensitive and resistant MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun. 188: 1122-1130.
19. BOONYARATANAKORNKIT, V., D.D. STRONG, S. MOHAN, et al. 1999. Progesterone stimulation of human insulin-like growth factor-binding protein-5 gene transcription in human osteoblasts is mediated by a CACCC sequence in the proximal promoter. J. Biol. Chem. 274: 26431-26438.
20. VITALI, R., V. CESI, M.R. NICOTRA, et al. 2003. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int. J. Cancer 106: 147-152.
21. EL-BADRY, O.M. 1991. Insulin-like growth factor II gene expression in human neuroblastoma. Prog. Clin. Biol. Res. 366: 249-256.
22. SCHNEIDER, M.R., E. WOLF, A. HOEFLICH & H. LAHM. 2002. IGF-binding protein-5: flexible player in the IGF system and effector on its own. J. Endocrinol. 172: 423-440.
23. DONG, Y. & E. CANALIS. 1995. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 136: 2000-2006.